Arch Therapeutics, Inc.

New Filing

CIK: 0001537561·Biotechnology·NEVADA·Filed: Jun 15, 2020

Total Offering

$2,000,000

Amount Sold

$550,000

Investors

4

First Sale

Jun 4, 2020

Offering Details

Type: Debt, Security to be Acquired
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Terrence W. Norchi	Related Person
Punit Dhillon	Related Person
James R. Sulat	Related Person
Richard E. Davis	Related Person

Company

Arch Therapeutics, Inc.

235 WALNUT STREET, SUITE 6

FRAMINGHAM, MA, 01702

617-431-2313

SEC Filing

0000905718-20-000578

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.